Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix
Authors:
Open Access
- 1 June 1990
- journal article
- Published by American Society of Hematology in Blood
- Vol. 75 (11) , 2204-2212
Abstract
Mast cells are widely distributed in perivascular connective tissues, especially in areas of active tumor growth and vascular reactivity. Incubation of metabolically [35S]O4 = -labeled subendothelial extracellular matrix (ECM) with lysates of bone marrow-derived mouse mast cells (BMMC) resulted in extensive degradation of heparan sulfate (HS) into fragments 5 to 6 times smaller than intact HS side chains. A much lower activity (seven- to eightfold) was expressed by intact BMMC incubated in contact with the ECM. These fragments were not produced in the presence of heparin, were sensitive to deamination with nitrous acid, and resistant to further degradation with papain or chondroitinase ABC. These results indicate that an endoglycosidase (heparanase) is involved in BMMC-mediated degradation of HS in the subendothelial ECM. Heparanase activity was not detected in medium conditioned by cultured BMMC, or in lysates of Ableson transformed BMMC and rat basophilic leukemic (RBL) cells. Both heparanase and beta- hexosaminidase, a mast cell granule enzyme, were released on degranulation of BMMC induced by the calcium ionophore A23187, or by exposure to IgE-Ag, suggesting that heparanase is localized in the cell granules. Under these conditions, less than 5% of the cellular content of lactate dehydrogenase were released. Degradation of the ECM-HS by the mast cell heparanase and the associated release of HS-bound endothelial cell growth factors that are stored in ECM (Vlodavsky et al, Proc Natl Acad Sci USA 84:2292, 1987; Bashkin et al, Biochemistry 28:1737, 1989) may play a role in the proposed mast cell-mediated stimulation of neovascularization.Keywords
This publication has 18 references indexed in Scilit:
- Characterization and functional studies of rheumatoid synovial mast cells: Activation by secretagogues, anti‐IgE, and a histamine‐releasing lymphokineArthritis & Rheumatism, 1986
- Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.Journal of Biological Chemistry, 1984
- Are factors originating from serum, plasma, or cultured cells involved in the growth‐promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells?Journal of Cellular Physiology, 1983
- Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-beta-D-glucuronidases.Journal of Biological Chemistry, 1982
- Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate.Journal of Biological Chemistry, 1982
- Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells.Journal of Biological Chemistry, 1982
- Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plasticCell, 1980
- A proteoglycan form of heparin and its degradation to single-chain molecules.Journal of Biological Chemistry, 1978
- Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factorsExperimental Eye Research, 1977
- The relationship of the tissue mast cells to the blood vessels in the ratThe Journal of Pathology and Bacteriology, 1953